0001209191-17-056611.txt : 20171011 0001209191-17-056611.hdr.sgml : 20171011 20171011142428 ACCESSION NUMBER: 0001209191-17-056611 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171010 FILED AS OF DATE: 20171011 DATE AS OF CHANGE: 20171011 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Foley Todd CENTRAL INDEX KEY: 0001473930 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38223 FILM NUMBER: 171132415 MAIL ADDRESS: STREET 1: THE JOHN HANCOCK TOWER STREET 2: 200 CLARENDON STREET 54TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RHYTHM PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001649904 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462159271 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 BOYLSTON STREET STREET 2: 11TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 857-264-4280 MAIL ADDRESS: STREET 1: 500 BOYLSTON STREET STREET 2: 11TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: RHYTHM METABOLIC, INC. DATE OF NAME CHANGE: 20150803 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-10-10 0 0001649904 RHYTHM PHARMACEUTICALS, INC. RYTM 0001473930 Foley Todd C/O MPM ASSET MANAGEMENT 450 KENDALL STREET CAMBRIDGE MA 02142 1 0 1 0 Common Stock 2017-10-10 4 C 0 2567014 A 2596392 I See Footnote Common Stock 2017-10-10 4 P 0 100000 17.00 A 2696392 I See Footnote Series A Preferred Stock 2017-08-18 4 A 0 3015915 1.00 A Common Stock 328889 3015915 I See Footnote Series A Preferred Stock 2017-10-10 4 C 0 7651831 0.00 D Common Stock 834441 0 I See Footnote Series A-1 Junior Preferred Stock 2017-10-10 4 C 0 15887703 0.00 D Common Stock 1732573 0 I See Footnote Each share of preferred stock converted into approximately 0.10905125 shares of common stock upon the closing of the issuer's initial public offering. The shares had no expiration date. The shares are held as follows: 2,499,299 by MPM BioVentures V, L.P. ("BV V") and 97,093 by MPM Asset Management Investors BV5 LLC ("AM BV5"). MPM BioVentures V GP LLC and MPM BioVentures V LLC ("BV LLC") are the direct and indirect general partners of BV V and BV LLC is the manager of AM BV5. Ansbert Gadicke, Luke Evnin and Todd Foley are the members of BV LLC. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein. Shares were purchased as follows: 96,260 by BV V and 3,740 by AM BV5. Shares are held as follows: 2,595,559 by BV V and 100,833 by AM BV5. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein. Shares were purchased as follows: 2,903,134 by BV V and 112,781 by AM BV5. Reflects a transaction with the Issuer prior to its Section 12 registration which occurred within 6 months of of the post-registration transaction reported on this Form 4. The shares of Series A Preferred Stock were held as follows: 7,365,688 by BV V and 286,143 by AM BV5. The shares of Series A-1 Junior Preferred Stock were held as follows: 15,293,569 by BV V and 594,134 by AM BV5. /s/ Todd Foley 2017-10-11